Upadacitinib Clears Atopic Dermatitis Faster Than Dupilumab Upadacitinib Clears Atopic Dermatitis Faster Than Dupilumab

A new JAK1 inhibitor provided greater symptom relief than dupilumab in an atopic dermatitis trial.Medscape Medical News

Source: Medscape Dermatology Headlines - April 23, 2021 Category: Dermatology Tags: Dermatology News Source Type: news